Talastine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49AB2PA48B. European Medicines Agency schedules Talastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10801MIG. Talastine generally arises in the molecular formula C19H21N3O. The term TALASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 10, 1968, list 8.) TALASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule talastine under HS 29339990 and SITC 51577. As of Q4 2014, TALASTINE remains the US FDA Preferred Term for this commodity. Talastine bears US NLM identifiers UMLS ID C0084711 and NCI Concept Code C73057. SMILES: O=C1N(NC(C2C1CCCC2)CC1CCCCC1)CCN(C)C.